ES2570609T3 - Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal - Google Patents

Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal

Info

Publication number
ES2570609T3
ES2570609T3 ES08827058T ES08827058T ES2570609T3 ES 2570609 T3 ES2570609 T3 ES 2570609T3 ES 08827058 T ES08827058 T ES 08827058T ES 08827058 T ES08827058 T ES 08827058T ES 2570609 T3 ES2570609 T3 ES 2570609T3
Authority
ES
Spain
Prior art keywords
colorectal cancer
aminoacylase
testing
vitro diagnosis
suffering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08827058T
Other languages
English (en)
Inventor
Jean-Philippe Charrier
Geneviève Choquet-Kastylevsky
Dominique Rolland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Application granted granted Critical
Publication of ES2570609T3 publication Critical patent/ES2570609T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Procedimiento de diagnóstico in vitro del cáncer colorrectal por determinación del aumento de la concentración, con respecto a los valores determinados para los sujetos sanos, del marcador Aminoacilasa 1 en una muestra biológica procedente de un paciente sospechoso de padecer cáncer colorrectal.
ES08827058T 2007-07-19 2008-07-10 Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal Active ES2570609T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705201A FR2919062B1 (fr) 2007-07-19 2007-07-19 Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
PCT/FR2008/051290 WO2009019366A2 (fr) 2007-07-19 2008-07-10 Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal

Publications (1)

Publication Number Publication Date
ES2570609T3 true ES2570609T3 (es) 2016-05-19

Family

ID=38912485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08827058T Active ES2570609T3 (es) 2007-07-19 2008-07-10 Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal

Country Status (9)

Country Link
US (1) US8367362B2 (es)
EP (1) EP2167970B1 (es)
JP (1) JP5559050B2 (es)
CN (1) CN102124343B (es)
AU (1) AU2008285555B2 (es)
CA (1) CA2693090A1 (es)
ES (1) ES2570609T3 (es)
FR (1) FR2919062B1 (es)
WO (1) WO2009019366A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102565267B (zh) * 2012-01-06 2014-12-10 北京师范大学 筛查结直肠癌的试剂盒
CN102662012B (zh) * 2012-05-08 2014-06-11 北京师范大学 筛查结直肠腺瘤的试剂盒
FR3001805B1 (fr) 2013-02-01 2015-02-20 Biomerieux Sa Procede de detection d'un cancer colorectal
EP3466975A1 (en) * 2017-10-05 2019-04-10 Laboratoire Français du Fractionnement et des Biotechnologies A specific binding molecule directed against galectin-3 protein
US20210214797A1 (en) * 2018-06-01 2021-07-15 Geneoscopy, Llc Detection method

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920484A1 (de) 1979-05-21 1980-12-04 Bosch Gmbh Robert Messeinrichtung mit magnetischem kreis zum messen eines gleichstroms
US4529931A (en) * 1983-04-07 1985-07-16 Ford Motor Company Single-coil current measuring circuit
FR2581456B1 (fr) 1985-05-02 1987-07-17 Pasteur Institut Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
US5360715A (en) * 1988-06-07 1994-11-01 California Institute Of Technology Plastin isoforms and their uses
US5002870A (en) * 1988-06-07 1991-03-26 California Institute For Medical Research Plastin isoforms and their use
JP2816175B2 (ja) 1989-04-28 1998-10-27 三菱電機株式会社 直流電流測定装置
US5223789A (en) * 1989-06-23 1993-06-29 Fuji Electric Co., Ltd. AC/DC current detecting method
JPH0464068A (ja) 1990-07-02 1992-02-28 Fuji Electric Co Ltd 直流電流検出方法
CA2054149A1 (en) 1990-10-29 1992-04-30 Eric Pringault Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals
JP2892171B2 (ja) * 1991-03-22 1999-05-17 寳酒造株式会社 ポリペプチド
US6291205B1 (en) * 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
US6001632A (en) * 1996-05-15 1999-12-14 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
DE19642472A1 (de) 1996-10-15 1998-04-16 Abb Research Ltd Flußkompensierter Stromsensor
DE69934139D1 (de) 1998-12-01 2007-01-04 Wrair Walter Reed Army Inst Of Diagnose von krebsstadium oder aggressivität
AU3479700A (en) 1999-02-22 2000-09-14 Incyte Pharmaceuticals, Inc. Genes associated with diseases of the colon
EP1619206A3 (en) * 1999-04-09 2006-02-15 Rigshospitalet Tissue inhibitor of matrix metallproteinases type-1 (TIMP-1) as a cancer marker
WO2001022920A2 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU2001289864A1 (en) 2000-09-08 2002-03-22 Bayer Aktiengesellschaft Regulation of human protein disulfide isomerase-like enzyme
US20040110668A1 (en) * 2000-10-02 2004-06-10 Burgess Christopher C. Nucleic acid sequences differentially expressed in cancer tissue
US20020160382A1 (en) * 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
AU2002232407A1 (en) * 2000-10-30 2002-05-15 Board Of Regents, The University Of Texas System Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
US20030082533A1 (en) * 2001-01-26 2003-05-01 Henry Yue Intelectin
AU2002251844A1 (en) * 2001-02-02 2002-10-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
GB0208331D0 (en) 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
KR100595364B1 (ko) 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
WO2005015218A1 (en) 2003-07-21 2005-02-17 Roche Diagnostics Gmbh Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
EP1649289B1 (en) * 2003-07-21 2008-10-22 Roche Diagnostics GmbH Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
WO2005015226A1 (en) 2003-08-08 2005-02-17 Roche Diagnostics Gmbh Use of protein t-plastin (plst) as a marker for colorectal cancer
CN1922490B (zh) 2004-02-19 2012-07-04 耶鲁大学 使用蛋白质组学技术鉴定癌症蛋白生物标志物的方法
CN101023185A (zh) * 2004-05-27 2007-08-22 威特克斯医药股份有限公司 用于监测impdh通路抑制作用的生物学标记
JP2008504018A (ja) * 2004-06-03 2008-02-14 ジョンズ ホプキンス ユニバーシティ 細胞増殖または新生物性障害に関してスクリーニングする方法
WO2006015079A2 (en) 2004-07-27 2006-02-09 Yale University Erm family binding agents and their use in diagnosis and treatment of proliferative conditions
AT500719B1 (de) 2004-09-08 2010-06-15 Red Bull Gmbh Chaperone als tumormarker
EP1838867B1 (en) 2005-01-06 2011-03-09 Eastern Virginia Medical School Apolipoprotein a-ii isoform as a biomarker for prostate cancer
US20060192550A1 (en) 2005-02-25 2006-08-31 Sandquist David A Current sensor with magnetic toroid single frequency detection scheme
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
CA2611173C (en) 2005-06-24 2019-11-12 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer
EP1861716A2 (en) 2005-08-18 2007-12-05 Zadec Aps Protein markers for diagnosing if colorectal cancer and use of said markers as drug targets for the treatment of said cance type
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
CN1967246A (zh) * 2005-11-18 2007-05-23 上海中科新生命生物科技有限公司 酰化氨基酸水解酶1及其抗体检测肝癌的应用
EP1971359A2 (en) 2005-12-16 2008-09-24 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
WO2007140352A2 (en) 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers
CA2660286A1 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
WO2008028968A2 (en) 2006-09-08 2008-03-13 Institut Gustave Roussy Compounds regulating calreticulin, kdel receptor and/or erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
US20100111973A1 (en) 2006-09-22 2010-05-06 Glenn Dranoff Methods for treating mica-related disorders
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
FR2919064B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919065B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919060B1 (fr) * 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
US9726670B2 (en) * 2007-07-19 2017-08-08 Biomerieux Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
FR2933773B1 (fr) * 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal

Also Published As

Publication number Publication date
CN102124343A (zh) 2011-07-13
FR2919062B1 (fr) 2009-10-02
US20100129844A1 (en) 2010-05-27
AU2008285555A1 (en) 2009-02-12
FR2919062A1 (fr) 2009-01-23
AU2008285555B2 (en) 2014-08-14
WO2009019366A3 (fr) 2009-05-07
JP2010533850A (ja) 2010-10-28
EP2167970B1 (fr) 2016-02-17
CN102124343B (zh) 2014-07-02
CA2693090A1 (fr) 2009-02-12
WO2009019366A2 (fr) 2009-02-12
JP5559050B2 (ja) 2014-07-23
EP2167970A2 (fr) 2010-03-31
US8367362B2 (en) 2013-02-05

Similar Documents

Publication Publication Date Title
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
ES2570627T3 (es) Ensayo in vitro de Ezrina para el diagnóstico del cáncer colorrectal
ES2570631T3 (es) Procedimiento de determinación de la apolipoproteína AII para el diagnóstico in vitro del cáncer colorrectal
ES2656962T3 (es) Métodos para evaluar la receptividad del endometrio de una paciente
WO2006091412A3 (en) Adamts-7 as a biomarker for cancers of epithelial origin
BR112013010952A2 (pt) sistemas de rmn e métodos para a detecção rápida de analisados
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
BR112013010015A2 (pt) aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos
EA201400491A1 (ru) Сопровождающая диагностика для терапии с антигиалуроновым агентом и способы ее применения
ES2530843T3 (es) Métodos basados en microARN para el diagnóstico de cáncer de páncreas
AR077901A1 (es) Anticuerpo anti- c-met y su uso para la deteccion y diagnostico del cancer
BR112015003715A8 (pt) análise de raman, de infravermelho, ou de raman-infravermelho da estrutura de proteína de plasma de sangue periférico e sua relação para desenvolvimento cognitivo no mal de alzheimer
AR073231A1 (es) Metodos diagnosticos y tratamientos para los tumores independientes del vegf (factor de crecimiento endotelial vascular)
WO2010099137A3 (en) In situ methods for monitoring the emt status of tumor cells in vivo
ES2570609T3 (es) Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal
MA38042A2 (fr) Méthylglyoxal en tant que marqueur du cancer
ES2531368T3 (es) Métodos y kits para diagnosticar tumorigenicidad y determinar resistencia a los efectos antineoplásicos de la terapia antiestrógeno
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
FR2919061B1 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência
WO2015006657A8 (en) Method for the diagnosis and prognosis of cancer
ES2493069T3 (es) CYBP como marcador del cáncer de pulmón
BRPI0811429A2 (pt) método para a detecção da atividade in vivo de neurotripsina, uso do método e uso do fragmento c-terminal de 22-kda de agrina como biomarcador no diagnóstico e monitoramento de distúrbios relacionados à neurotripsina